Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Caribou Biosciences, Inc.
Caribou Biosciences Appoints Tina Albertson, MD, PhD, as Chief Medical Officer
August 12, 2024
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
Tickers
CRBU
Caribou Biosciences Reports Second Quarter 2024 Financial Results and Provides Business Update
August 06, 2024
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
Tickers
CRBU
Caribou Biosciences Announces Appointment of Terri Laufer, MD, to its Scientific Advisory Board
July 09, 2024
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
Tickers
CRBU
Caribou Biosciences Presents Encouraging Clinical Data from CB-010 ANTLER Phase 1 Trial in Second-line LBCL Patients at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
June 02, 2024
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
Tickers
CRBU
Caribou Biosciences to Host KOL Discussion with Webcast from the 2024 ASCO Annual Meeting and Participate in Upcoming Investor Conferences
May 30, 2024
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
Tickers
CRBU
Caribou Biosciences Reports First Quarter 2024 Financial Results and Provides Business Update
May 07, 2024
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
Tickers
CRBU
Caribou Biosciences to Participate in Upcoming Investor Conferences
May 01, 2024
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
Tickers
CRBU
Caribou Biosciences to Present Initial Dose Expansion Data from CB-010 ANTLER Phase 1 Trial in r/r B-NHL at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
April 24, 2024
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
Tickers
CRBU
Caribou Biosciences Announces Oral Presentation on In Vivo Cas12a chRDNA Genome Editing at the 27th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)
April 15, 2024
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
Tickers
CRBU
Caribou Biosciences Expands Clinical Development of CB-010 with FDA Clearance of IND in Lupus
April 04, 2024
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
Tickers
CRBU
Caribou Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
March 11, 2024
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
Tickers
CRBU
Caribou Biosciences to Present Preclinical Data on CB-012, an Allogeneic Anti-CLL-1 CAR-T Cell Therapy, at the American Association for Cancer Research (AACR) Annual Meeting
March 05, 2024
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
Tickers
CRBU
Caribou Biosciences to Participate in Upcoming Investor Conferences
February 15, 2024
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
Tickers
CRBU
Caribou Biosciences Appoints Tim Kelly as Chief Technology Officer and Highlights Multiple Clinical Catalysts Expected in 2024
January 07, 2024
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
Tickers
CRBU
Caribou Biosciences Provides Regulatory Update on CB-010 Pivotal Plan with Phase 3 Trial Initiation Expected by YE 2024
December 12, 2023
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
Tickers
CRBU
Caribou Biosciences Reports Third Quarter 2023 Financial Results and Provides Business Update
November 07, 2023
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
Tickers
CRBU
Caribou Biosciences Announces Appointment of Sundar Jagannath, MD, to its Scientific Advisory Board
November 06, 2023
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
Tickers
CRBU
Caribou Biosciences to Participate in Upcoming Investor Conferences
November 01, 2023
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
Tickers
CRBU
Caribou Biosciences Announces FDA Clearance of IND Application for CB-012, an Allogeneic Anti-CLL-1 CAR-T Cell Therapy for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
October 18, 2023
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
Tickers
CRBU
Caribou Biosciences Appoints Reigin Zawadzki as Chief People Officer
September 27, 2023
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
Tickers
CRBU
Caribou Biosciences to Participate in Upcoming Investor Conferences
August 29, 2023
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
Tickers
CRBU
Caribou Biosciences Reports Second Quarter 2023 Financial Results and Provides Business Update
August 08, 2023
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
Tickers
CRBU
Caribou Biosciences Announces Pricing of Upsized $125 Million Public Offering
July 13, 2023
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
Tickers
CRBU
Caribou Biosciences Announces Proposed Public Offering of Common Stock
July 13, 2023
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
Tickers
CRBU
Caribou Biosciences Reports Positive Clinical Data from Dose Escalation of CB-010 ANTLER Phase 1 Trial in r/r B-NHL
July 13, 2023
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
Tickers
CRBU
Caribou Biosciences Announces $25 Million Equity Investment from Pfizer
July 06, 2023
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
Tickers
CRBU
PFE
Caribou Biosciences to Participate in Upcoming Investor Conferences
May 31, 2023
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
Tickers
CRBU
Caribou Biosciences Reports First Quarter 2023 Financial Results and Provides Business Update
May 09, 2023
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
Tickers
CRBU
Caribou Biosciences Announces Appointment of Stephen J. Schuster, MD, to its Scientific Advisory Board
May 08, 2023
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
Tickers
CRBU
Caribou Biosciences to Participate in Upcoming Investor Conferences
May 01, 2023
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
Tickers
CRBU
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.